Q3 2025 Quanterix Corp Earnings Call Transcript

Nov 10, 2025 / 09:30 PM GMT

Release Date Price: $5.12 (+3.64%)

Transcript 10-Q8-K

Key Points

Positve

Quanterix Corp (QTRX) delivered on its revenue expectations despite a challenging environment, generating $40 million in Q3.
The integration of Akoya is progressing well, with $67 million of the targeted $85 million in synergies already realized.
Significant investments are being made in Alzheimer's diagnostics and new assays, with $27 million invested in R&D year-to-date.
The company is on track to end the year with approximately $120 million in cash and no debt, aiming for cash flow break-even in 2026.
Early commercial momentum is seen in combining tissue and blood insights, with cross-selling opportunities expanding in pharma and academic markets.

Negative

Samoa's consumables revenue declined by 36% year-over-year due to smaller order sizes, despite consistent order volume.
The US academic and pharmaceutical markets showed weakness, contributing to a 30% decline in US academic revenue and a 23% decline in pharma revenue.
Operating expenses increased to $54.5 million, including $15 million related to acquisition and integration costs.
The company reported an adjusted EBITDA loss of $11.9 million, compared to a $5.5 million loss in the prior year.
There is uncertainty in the market, particularly regarding funding flows, leading to a cautious outlook for Q4 revenue.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

QTRX.OQ - Quanterix Corp
Q3 2025 Quanterix Corp Earnings Call
Nov 10, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and thank you for standing by. My name is Tiffany and I will be your conference operator today. At this time, I would like to welcome everyone to the Quanterix Corporation Q3 2025 earnings call.

All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply press star, then the number one on your telephone keypad.

I would now like to turn the call over to Joshua Young, head of investor relations. Joshua, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.